Argent Trust Company’s Teva Pharmaceuticals TEVA Stock Holding History

Argent Trust Company’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$797K	Sell	14,127 -12	-0.1%	-$778	0.35%	72
2015 Q2	$836K	Buy	+14,139	New	+$872K	0.33%	77
2014 Q2	–	Sell	-15,423	Closed	-$815K	–	181
2014 Q1	$815K	Sell	15,423 -13,524	-47%	-$625K	0.31%	80
2013 Q4	$1.16M	Sell	28,947 -2,160	-7%	-$85.1K	0.44%	69
2013 Q3	$1.18M	Sell	31,107 -700	-2%	-$27.3K	0.5%	65
2013 Q2	$1.25M	Buy	+31,807	New	+$1.24M	0.55%	60

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Argent Trust Company's TEVA Position: Q3 2015 in Review

Argent Trust Company reduced its Teva Pharmaceuticals (TEVA) stake by 0.08% in Q3 2015, selling an estimated $778 and leaving 14,127 shares worth $797K. The position accounts for 0.35% of the portfolio, ranked #72.

Argent Trust Company first reported a position in TEVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.25M in Q2 2013. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Argent Trust Company held 14,127 shares of Teva Pharmaceuticals worth $797K as of Q3 2015.
Argent Trust Company sold 12 Teva Pharmaceuticals shares in Q3 2015, an estimated $778.
Teva Pharmaceuticals made up 0.35% of Argent Trust Company's portfolio in Q3 2015, its #72 holding.
Argent Trust Company first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Argent Trust Company's Teva Pharmaceuticals position peaked at $1.25M in Q2 2013.
824 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.